What should primary care docs know about LDL-lowering effects of the PCSK9 inhibitor evolocumab? A leading cardiologist discusses results of the FOURIER trial.

Knowing who is at risk for a cardiac event after surgery may soon be easier. Drs Cassoobhoy and Walton-Shirley discuss the VISION trial presented at ACC.17.

Dr Rachel Levine discusses what clinicians should know about gender identity issues--something she, a transgender woman, knows about firsthand.

Patient resistance is a well-known barrier to the use of insulin, but what about clinician resistance?

Dr De Ferrari provides details on a substudy of the ARISTOTLE trial that examined digoxin blood levels and mortality in patients with and without heart failure.

Dr Arefa Cassoobhoy highlights one of the week's most important news stories for primary care.

Ethicist Art Caplan talks with oncologist Maurie Markman about his concerns over physician-assisted dying.

To respond promptly, clinicians need to understand what constitutes a rabies exposure and how to properly dose the vaccine.

Drs Shubrook and Bertheau discuss alternatives to branded basal insulins and how to make the switch.

Dr Arefa Cassoobhoy highlights one of the week's important news stories for primary care.